Pharmazeutische Biotechnologie, Universität des Saarlandes, 66123 Saarbrücken, Germany.
School of Pharmacy, Mongolian National University of Medical Sciences, S. Zorig Street, 14210 Ulaanbaatar, Mongolia.
Biomolecules. 2020 Jul 18;10(7):1074. doi: 10.3390/biom10071074.
Pyrrolopyrimidines are an important class of natural products with a broad spectrum of biological activities, including antibacterial, antifungal, antiviral, anticancer or anti-inflammatory. Here, we present the identification of a biosynthetic gene cluster from the rare actinomycete strain DSM 43870, which leads to the production of huimycin, a new member of the pyrrolopyrimidine family of compounds. The huimycin gene cluster was successfully expressed in the heterologous host strain Del14. The compound was purified, and its structure was elucidated by means of nuclear magnetic resonance spectroscopy. The minimal huimycin gene cluster was identified through sequence analysis and a series of gene deletion experiments. A model for huimycin biosynthesis is also proposed in this paper.
吡咯并嘧啶类化合物是一类具有广泛生物活性的天然产物,包括抗菌、抗真菌、抗病毒、抗癌或抗炎活性。在这里,我们从稀有放线菌菌株 DSM 43870 中鉴定出一个生物合成基因簇,该基因簇导致产生 huimycin,这是吡咯并嘧啶类化合物的一个新成员。huimycin 基因簇在异源宿主菌株 Del14 中成功表达。通过核磁共振波谱法对该化合物进行了纯化和结构解析。通过序列分析和一系列基因缺失实验,确定了最小的 huimycin 基因簇。本文还提出了 huimycin 生物合成的模型。